{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Bonnet G"],"funding":["FIC NIH HHS","Wellcome Trust"],"pagination":["1288"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10666325"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["23(1)"],"pubmed_abstract":["<h4>Background</h4>Rapid diagnostic testing may support improved treatment of COVID patients. Understanding COVID testing and care pathways is important for assessing the impact and cost-effectiveness of testing in the real world, yet there is limited information on these pathways in low-and-middle income countries (LMICs). We therefore undertook an expert consultation to better understand testing policies and practices, clinical screening, the profile of patients seeking testing or care, linkage to care after testing, treatment, lessons learnt and expected changes in 2023.<h4>Methods</h4>We organized a qualitative consultation with ten experts from seven LMICs (India, Indonesia, Malawi, Nigeria, Peru, South Africa, and Zimbabwe) identified through purposive sampling. We conducted structur"],"journal":["BMC health services research"],"pubmed_title":["\"We usually see a lot of delay in terms of coming for or seeking care\": an expert consultation on COVID testing and care pathways in seven low- and middle-income countries."],"pmcid":["PMC10666325"],"funding_grant_id":["WT200901/Z/16/Z","D43 TW007393"],"pubmed_authors":["Corbett EL","Majam M","Jit M","Lescano AG","Chavula C","Chifamba HN","Suwantika AA","Mbo D","Tovar MA","Vassall A","Bonnet G","Bimba J","Divala T","Yadav P"],"additional_accession":[]},"is_claimable":false,"name":"\"We usually see a lot of delay in terms of coming for or seeking care\": an expert consultation on COVID testing and care pathways in seven low- and middle-income countries.","description":"<h4>Background</h4>Rapid diagnostic testing may support improved treatment of COVID patients. Understanding COVID testing and care pathways is important for assessing the impact and cost-effectiveness of testing in the real world, yet there is limited information on these pathways in low-and-middle income countries (LMICs). We therefore undertook an expert consultation to better understand testing policies and practices, clinical screening, the profile of patients seeking testing or care, linkage to care after testing, treatment, lessons learnt and expected changes in 2023.<h4>Methods</h4>We organized a qualitative consultation with ten experts from seven LMICs (India, Indonesia, Malawi, Nigeria, Peru, South Africa, and Zimbabwe) identified through purposive sampling. We conducted structur","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Nov","modification":"2025-04-06T23:14:06.661Z","creation":"2024-11-14T13:17:24.569Z"},"accession":"S-EPMC10666325","cross_references":{"pubmed":["37996862"],"doi":["10.1186/s12913-023-10305-0"]}}